Naveen Rajamohan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Naveen Rajamohan has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Barun Bagga
NYU Langone Health, New York, United States
2 shared publications Gaurav Khatri
Department of Radiology, UT Southwestern Medical Center, 1801 Inwood Rd, Dallas, Texas, 75390, UNITED STATES
2 shared publications- Mandeep Singh Virk
Department of Abdominal Imaging, University of Pittsburgh, Pittsburgh, United States
2 shared publications - Aashna Karbhari
Department of Radiology, University of Washington School of Medicine, 1959 NE Pacific Street, Seattle, WA 98195
1 shared publication - Achille Mileto
Department of Radiology, University of Washington, Seattle, USA
1 shared publication - Ajit Harishkumar Goenka
Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA
1 shared publication
Latest Publications
- 16 October 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-16
Deep learning reconstruction in prostate MRI: technical principles, clinical applications, and future directions
Multiparametric magnetic resonance imaging (mpMRI) has become integral to the detection, localization, risk stratification, and management of prostate cancer. Increasing utilization of prostate MRI in screening, active surveillance, targeted biopsy guidance, and treatment planning has amplified the demand for faster imaging protocols while maintaining high diagnostic quality. Conventional MRI acceleration strategies, including parallel imaging and compressed sensing, improve acquisition efficiency but remain limited by trade-offs involving signal-to-noise ratio (SNR), image sharpness, artifacts, and reconstruction complexity. Deep learning reconstruction (DLR) has emerged as a promising artificial intelligence–based approach for MRI acceleration and image enhancement. Unlike traditional reconstruction methods that rely primarily on predefined mathematical models, DLR uses neural networks to learn image priors and reconstruction features from MRI data. Published studies suggest that DLR may enable accelerated acquisitions while maintaining or, in some settings, improving image quality through denoising, artifact reduction, and improved spatial resolution and lesion conspicuity. However, these effects vary according to the reconstruction algorithm, sequence, acceleration factor, and clinical setting. Variational networks combine physics-based MRI constraints with learned regularization and represent an important framework for DLR. In prostate MRI, available studies have reported substantial reductions in acquisition time for T2-weighted and diffusion-weighted imaging while generally maintaining perceived image quality. Reported benefits include improved lesion conspicuity, reader confidence, and delineation of anatomic structures. Current evidence suggests that DLR generally preserves PI-RADS assessment and diagnostic performance rather than systematically altering lesion categorization; however, evidence demonstrating improvements in diagnostic accuracy or clinical outcomes remains limited. Important limitations include vendor and algorithm dependence, potential reconstruction artifacts, variability in quantitative imaging metrics, limited multicenter validation, and uncertain generalizability across scanners, protocols, and clinical settings. This review summarizes the technical principles underlying DLR, discusses current clinical applications in prostate MRI, highlights representative studies and workflow implications, reviews limitations, and outlines future directions for this rapidly evolving technology.
- 16 October 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-16
Deep learning reconstruction in prostate MRI: technical principles, clinical applications, and future directions
Multiparametric magnetic resonance imaging (mpMRI) has become integral to the detection, localization, risk stratification, and management of prostate cancer. Increasing utilization of prostate MRI in screening, active surveillance, targeted biopsy guidance, and treatment planning has amplified the demand for faster imaging protocols while maintaining high diagnostic quality. Conventional MRI acceleration strategies, including parallel imaging and compressed sensing, improve acquisition efficiency but remain limited by trade-offs involving signal-to-noise ratio (SNR), image sharpness, artifacts, and reconstruction complexity. Deep learning reconstruction (DLR) has emerged as a promising artificial intelligence–based approach for MRI acceleration and image enhancement. Unlike traditional reconstruction methods that rely primarily on predefined mathematical models, DLR uses neural networks to learn image priors and reconstruction features from MRI data. Published studies suggest that DLR may enable accelerated acquisitions while maintaining or, in some settings, improving image quality through denoising, artifact reduction, and improved spatial resolution and lesion conspicuity. However, these effects vary according to the reconstruction algorithm, sequence, acceleration factor, and clinical setting. Variational networks combine physics-based MRI constraints with learned regularization and represent an important framework for DLR. In prostate MRI, available studies have reported substantial reductions in acquisition time for T2-weighted and diffusion-weighted imaging while generally maintaining perceived image quality. Reported benefits include improved lesion conspicuity, reader confidence, and delineation of anatomic structures. Current evidence suggests that DLR generally preserves PI-RADS assessment and diagnostic performance rather than systematically altering lesion categorization; however, evidence demonstrating improvements in diagnostic accuracy or clinical outcomes remains limited. Important limitations include vendor and algorithm dependence, potential reconstruction artifacts, variability in quantitative imaging metrics, limited multicenter validation, and uncertain generalizability across scanners, protocols, and clinical settings. This review summarizes the technical principles underlying DLR, discusses current clinical applications in prostate MRI, highlights representative studies and workflow implications, reviews limitations, and outlines future directions for this rapidly evolving technology.
- 29 June 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-14
Pancreatic malignancy in disguise: imaging pitfalls and mimickers of pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy and continues to rank among the leading causes of cancer-related death worldwide. Imaging plays a central role in detection, staging, and treatment planning; nevertheless, PDAC remains one of the most frequently missed or misdiagnosed abdominal malignancies in clinical practice. Diagnostic challenges arise from subtle early imaging findings, anatomic blind spots within the pancreas, and a wide spectrum of inflammatory, benign, and malignant entities that closely mimic PDAC, such as focal acute pancreatitis, mass-forming chronic pancreatitis, autoimmune pancreatitis, groove pancreatitis, neuroendocrine tumors, lymphoma, metastases, solid pseudopapillary neoplasms and focal fatty infiltration. This narrative review provides a comprehensive, imaging-focused discussion of PDAC and its mimickers, with an emphasis on practical problem-solving strategies to reliably differentiate mimics from PDAC and improve diagnostic confidence, reduce unnecessary interventions, and facilitate timely and appropriate patient management.
- 29 June 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-14
Pancreatic malignancy in disguise: imaging pitfalls and mimickers of pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy and continues to rank among the leading causes of cancer-related death worldwide. Imaging plays a central role in detection, staging, and treatment planning; nevertheless, PDAC remains one of the most frequently missed or misdiagnosed abdominal malignancies in clinical practice. Diagnostic challenges arise from subtle early imaging findings, anatomic blind spots within the pancreas, and a wide spectrum of inflammatory, benign, and malignant entities that closely mimic PDAC, such as focal acute pancreatitis, mass-forming chronic pancreatitis, autoimmune pancreatitis, groove pancreatitis, neuroendocrine tumors, lymphoma, metastases, solid pseudopapillary neoplasms and focal fatty infiltration. This narrative review provides a comprehensive, imaging-focused discussion of PDAC and its mimickers, with an emphasis on practical problem-solving strategies to reliably differentiate mimics from PDAC and improve diagnostic confidence, reduce unnecessary interventions, and facilitate timely and appropriate patient management.
- Open Access
- 14 May 2026
- Published by Elsevier in The Royal College of Radiologists Open
- Vol. 4
Peroneal compartment pathology from a tertiary care county hospital: Imaging-based epidemiological study with clinical correlation
- 14 May 2026
- Published by Elsevier in The Royal College of Radiologists Open
- Vol. 4
Open AccessPeroneal compartment pathology from a tertiary care county hospital: Imaging-based epidemiological study with clinical correlation
- Open Access
- 22 October 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (21) , 215004
Exploring radiomic and topological features to evaluate treatment response in rectal cancer
Objective. This study investigates the potential of topological data analysis (TDA) in conjunction with conventional radiomics applied to longitudinal T2-weighted magnetic resonance imaging (MRI) to evaluate treatment response following neoadjuvant therapy, with or without anti-CD40 immunotherapy, in patients with locally advanced rectal cancer. Approach. Paired pre- and post-treatment MRIs from 21 patients enrolled in the INNATE trial (NCT04130854) were analyzed, including Arm1 (radiation, chemotherapy, and anti-CD40 immunotherapy; n = 12) and Arm2 (radiation and chemotherapy alone; n = 9). Patients were categorized as having a maximal response (MR) or a partial response (PR). Three complementary delta-based analyses were performed: (1) 3D radiomics, (2) 2D radiomics and sliding-windows analysis, and (3) topological feature extraction via TDA. Statistical analysis included cross-arm comparisons (Arm1 vs Arm2), response-based comparisons (MR vs PR), and detailed pairwise subgroup analyses. Main results. For 3D radiomic features, ΔVolume effectively distinguishes between treatment strategies, with Arm1 exhibiting greater tumor reduction compared to Arm2. ΔElongation differentiates between response groups, with MR showing negative values indicative of increased tumor sphericity. In 2D radiomic analysis, Gray-level-dependence -matrix texture features computed across varying sliding windows differentiate between treatment arms but not response groups. Topological analysis identified six features derived from Betti numbers and persistence lifetimes, capturing local heterogeneity in tumor texture, shape and filtration patterns. Among these, five features significantly differentiate response groups, while one distinguishes treatment arms. At a finer level of subgroup comparison, ΔBetti 2 demonstrates significant differences, distinguishing MR-Arm1 vs PR-Arm1 and MR-Arm1 vs MR-Arm2. Significance. This exploratory study suggests potential of topological features for outcome prediction in rectal cancer. These features may complement standard radiomics to enhance predictive performance as more data becomes available. Notably, the ability of topological features to distinguish maximal responders across treatment arms—with and without immunotherapy—may offer additional biological insights, potentially related to immune-mediated tumor response.
- 22 October 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (21) , 215004
Open AccessExploring radiomic and topological features to evaluate treatment response in rectal cancer
Objective. This study investigates the potential of topological data analysis (TDA) in conjunction with conventional radiomics applied to longitudinal T2-weighted magnetic resonance imaging (MRI) to evaluate treatment response following neoadjuvant therapy, with or without anti-CD40 immunotherapy, in patients with locally advanced rectal cancer. Approach. Paired pre- and post-treatment MRIs from 21 patients enrolled in the INNATE trial (NCT04130854) were analyzed, including Arm1 (radiation, chemotherapy, and anti-CD40 immunotherapy; n = 12) and Arm2 (radiation and chemotherapy alone; n = 9). Patients were categorized as having a maximal response (MR) or a partial response (PR). Three complementary delta-based analyses were performed: (1) 3D radiomics, (2) 2D radiomics and sliding-windows analysis, and (3) topological feature extraction via TDA. Statistical analysis included cross-arm comparisons (Arm1 vs Arm2), response-based comparisons (MR vs PR), and detailed pairwise subgroup analyses. Main results. For 3D radiomic features, ΔVolume effectively distinguishes between treatment strategies, with Arm1 exhibiting greater tumor reduction compared to Arm2. ΔElongation differentiates between response groups, with MR showing negative values indicative of increased tumor sphericity. In 2D radiomic analysis, Gray-level-dependence -matrix texture features computed across varying sliding windows differentiate between treatment arms but not response groups. Topological analysis identified six features derived from Betti numbers and persistence lifetimes, capturing local heterogeneity in tumor texture, shape and filtration patterns. Among these, five features significantly differentiate response groups, while one distinguishes treatment arms. At a finer level of subgroup comparison, ΔBetti 2 demonstrates significant differences, distinguishing MR-Arm1 vs PR-Arm1 and MR-Arm1 vs MR-Arm2. Significance. This exploratory study suggests potential of topological features for outcome prediction in rectal cancer. These features may complement standard radiomics to enhance predictive performance as more data becomes available. Notably, the ability of topological features to distinguish maximal responders across treatment arms—with and without immunotherapy—may offer additional biological insights, potentially related to immune-mediated tumor response.
- 26 May 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (12) , 6172-6191
Applications of artificial intelligence in abdominal imaging
The rapid advancements in artificial intelligence (AI) carry the promise to reshape abdominal imaging by offering transformative solutions to challenges in disease detection, classification, and personalized care. AI applications, particularly those leveraging deep learning and radiomics, have demonstrated remarkable accuracy in detecting a wide range of abdominal conditions, including but not limited to diffuse liver parenchymal disease, focal liver lesions, pancreatic ductal adenocarcinoma (PDAC), renal tumors, and bowel pathologies. These models excel in the automation of tasks such as segmentation, classification, and prognostication across modalities like ultrasound, CT, and MRI, often surpassing traditional diagnostic methods. Despite these advancements, widespread adoption remains limited by challenges such as data heterogeneity, lack of multicenter validation, reliance on retrospective single-center studies, and the “black box” nature of many AI models, which hinder interpretability and clinician trust. The absence of standardized imaging protocols and reference gold standards further complicates integration into clinical workflows. To address these barriers, future directions emphasize collaborative multi-center efforts to generate diverse, standardized datasets, integration of explainable AI frameworks to existing picture archiving and communication systems, and the development of automated, end-to-end pipelines capable of processing multi-source data. Targeted clinical applications, such as early detection of PDAC, improved segmentation of renal tumors, and improved risk stratification in liver diseases, show potential to refine diagnostic accuracy and therapeutic planning. Ethical considerations, such as data privacy, regulatory compliance, and interdisciplinary collaboration, are essential for successful translation into clinical practice. AI’s transformative potential in abdominal imaging lies not only in complementing radiologists but also in fostering precision medicine by enabling faster, more accurate, and patient-centered care. Overcoming current limitations through innovation and collaboration will be pivotal in realizing AI’s full potential to improve patient outcomes and redefine the landscape of abdominal radiology.
- 26 May 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (12) , 6172-6191
Applications of artificial intelligence in abdominal imaging
The rapid advancements in artificial intelligence (AI) carry the promise to reshape abdominal imaging by offering transformative solutions to challenges in disease detection, classification, and personalized care. AI applications, particularly those leveraging deep learning and radiomics, have demonstrated remarkable accuracy in detecting a wide range of abdominal conditions, including but not limited to diffuse liver parenchymal disease, focal liver lesions, pancreatic ductal adenocarcinoma (PDAC), renal tumors, and bowel pathologies. These models excel in the automation of tasks such as segmentation, classification, and prognostication across modalities like ultrasound, CT, and MRI, often surpassing traditional diagnostic methods. Despite these advancements, widespread adoption remains limited by challenges such as data heterogeneity, lack of multicenter validation, reliance on retrospective single-center studies, and the “black box” nature of many AI models, which hinder interpretability and clinician trust. The absence of standardized imaging protocols and reference gold standards further complicates integration into clinical workflows. To address these barriers, future directions emphasize collaborative multi-center efforts to generate diverse, standardized datasets, integration of explainable AI frameworks to existing picture archiving and communication systems, and the development of automated, end-to-end pipelines capable of processing multi-source data. Targeted clinical applications, such as early detection of PDAC, improved segmentation of renal tumors, and improved risk stratification in liver diseases, show potential to refine diagnostic accuracy and therapeutic planning. Ethical considerations, such as data privacy, regulatory compliance, and interdisciplinary collaboration, are essential for successful translation into clinical practice. AI’s transformative potential in abdominal imaging lies not only in complementing radiologists but also in fostering precision medicine by enabling faster, more accurate, and patient-centered care. Overcoming current limitations through innovation and collaboration will be pivotal in realizing AI’s full potential to improve patient outcomes and redefine the landscape of abdominal radiology.
- 1 August 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 312 (2) , e232914
MSKI-RADS: An MRI-based Musculoskeletal Infection Reporting and Data System for the Diagnosis of Extremity Infections
The MRI-based Musculoskeletal Infection Reporting and Data System provides standardized terminology and recommended management of imaging findings of peripheral extremity infections.
- 1 August 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 312 (2) , e232914
MSKI-RADS: An MRI-based Musculoskeletal Infection Reporting and Data System for the Diagnosis of Extremity Infections
The MRI-based Musculoskeletal Infection Reporting and Data System provides standardized terminology and recommended management of imaging findings of peripheral extremity infections.
- 1 August 2024
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 44 (8) , e230173
T1-weighted Motion Mitigation in Abdominal MRI: Technical Principles, Clinical Applications, Current Limitations, and Future Prospects
T1-weighted (T1W) pulse sequences are an indispensable component of clinical protocols in abdominal MRI but usually require multiple breath holds (BHs) during the examination, which not all patients can sustain. Patient motion can affect the quality of T1W imaging so that key diagnostic information, such as intrinsic signal intensity and contrast enhancement image patterns, cannot be determined. Patient motion also has a negative impact on examination efficiency, as multiple acquisition attempts prolong the duration of the examination and often remain noncontributory. Techniques for mitigation of motion-related artifacts at T1W imaging include multiple arterial acquisitions within one BH; free breathing with respiratory gating or respiratory triggering; and radial imaging acquisition techniques, such as golden-angle radial k-space acquisition (stack-of-stars). While each of these techniques has inherent strengths and limitations, the selection of a specific motion-mitigation technique is based on several factors, including the clinical task under investigation, downstream technical ramifications, patient condition, and user preference. The authors review the technical principles of free-breathing motion mitigation techniques in abdominal MRI with T1W sequences, offer an overview of the established clinical applications, and outline the existing limitations of these techniques. In addition, practical guidance for abdominal MRI protocol strategies commonly encountered in clinical scenarios involving patients with limited BH abilities is rendered. Future prospects of free-breathing T1W imaging in abdominal MRI are also discussed. ©RSNA, 2024 See the invited commentary by Fraum and An in this issue.
- 1 August 2024
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 44 (8) , e230173
T1-weighted Motion Mitigation in Abdominal MRI: Technical Principles, Clinical Applications, Current Limitations, and Future Prospects
T1-weighted (T1W) pulse sequences are an indispensable component of clinical protocols in abdominal MRI but usually require multiple breath holds (BHs) during the examination, which not all patients can sustain. Patient motion can affect the quality of T1W imaging so that key diagnostic information, such as intrinsic signal intensity and contrast enhancement image patterns, cannot be determined. Patient motion also has a negative impact on examination efficiency, as multiple acquisition attempts prolong the duration of the examination and often remain noncontributory. Techniques for mitigation of motion-related artifacts at T1W imaging include multiple arterial acquisitions within one BH; free breathing with respiratory gating or respiratory triggering; and radial imaging acquisition techniques, such as golden-angle radial k-space acquisition (stack-of-stars). While each of these techniques has inherent strengths and limitations, the selection of a specific motion-mitigation technique is based on several factors, including the clinical task under investigation, downstream technical ramifications, patient condition, and user preference. The authors review the technical principles of free-breathing motion mitigation techniques in abdominal MRI with T1W sequences, offer an overview of the established clinical applications, and outline the existing limitations of these techniques. In addition, practical guidance for abdominal MRI protocol strategies commonly encountered in clinical scenarios involving patients with limited BH abilities is rendered. Future prospects of free-breathing T1W imaging in abdominal MRI are also discussed. ©RSNA, 2024 See the invited commentary by Fraum and An in this issue.
- 27 July 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (1) , 305-318
MR imaging of penile pathology and prostheses
Penile MRI is a vital yet underutilized diagnostic tool that provides detailed information crucial for managing various penile pathologies. Due to its infrequent use, many radiology trainees lack confidence in interpreting these exams. This article reviews the anatomy, key technical considerations, and interpretive pearls for penile trauma, Peyronie’s disease, priapism, penile neoplasms, prosthesis evaluation, and a few miscellaneous conditions. Through illustrative case examples, this review aims to enhance the understanding and proficiency of radiologists in performing and interpreting penile MRI in these clinical scenarios.
- 27 July 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (1) , 305-318
MR imaging of penile pathology and prostheses
Penile MRI is a vital yet underutilized diagnostic tool that provides detailed information crucial for managing various penile pathologies. Due to its infrequent use, many radiology trainees lack confidence in interpreting these exams. This article reviews the anatomy, key technical considerations, and interpretive pearls for penile trauma, Peyronie’s disease, priapism, penile neoplasms, prosthesis evaluation, and a few miscellaneous conditions. Through illustrative case examples, this review aims to enhance the understanding and proficiency of radiologists in performing and interpreting penile MRI in these clinical scenarios.
- 26 May 2023
- Published by Elsevier in Pancreatology
- Vol. 23 (5) , 522-529
Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-of-care CTs
- 26 May 2023
- Published by Elsevier in Pancreatology
- Vol. 23 (5) , 522-529
Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-of-care CTs
- 1 December 2021
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 94 (1128)
CT texture analysis in evaluation of thymic tumors and thymic hyperplasia: correlation with the international thymic malignancy interest group (ITMIG) stage and WHO grade
Objectives: To evaluate the effectiveness of CT texture analysis (CTTA) in (1) differentiating Thymoma (THY) from thymic hyperplasia (TH) (2) low from high WHO grade, and (3) low from high Masaoka Koga (MK)/International Thymic Malignancy Interest Group (ITMIG) stages. Methods: After institute ethical clearance, this cross-sectional study analyzed 26 patients (THY-18, TH-8) who underwent dual energy CT (DECT) and surgery between January 2016 and December 2018. CTTA was performed using TexRad (Feedback Medical Ltd., Cambridge, UK- www.fbkmed.com ) by a single observer. Free hand regions of interest (ROIs) were placed over axial sections where there was maximum enhancement and homogeneity. Filtration histogram was used to generate six first-order texture parameters [mean, standard deviation (SD), mean of positive pixels (MPP), entropy, skewness, and kurtosis] at six spatial scaling factors “SSF 0, 2, 3, 4, 5, and 6”. Mann–Whitney test was applied among various categories and p value < 0.05 was considered significant. Three-step feature selection was performed to determine the best parameters among each category. Results: The best performing parameters were (1) THY vs TH- Mean at “SSF 0” (AUC: 0.8889) and MPP at “SSF 0” (AUC: 0.8889), (2) Low vs high WHO grade - no parameter showed statistical significance with good AUC, and (3) Low vs high MK/ITMIG stage- SD at “SSF 6” (AUC: 0.8052 and 0.8333 respectively]). Conclusion: CTTA revealed several parameters with excellent diagnostic performance in differentiating thymoma from thymic hyperplasia and MK/ITMIG high vs low stages. CTTA could potentially serve as a non-invasive tool for this stratification. Advances in knowledge: This study has employed texture analysis, a novel radiomics method on DECT scans to determine the best performing parameter and their corresponding cut-off values to differentiate among the above-mentioned categories. These new parameters may help add another layer of confidence to non-invasively stratify and prognosticate patients accurately which was only previously possible with a biopsy.
- 1 December 2021
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 94 (1128)
CT texture analysis in evaluation of thymic tumors and thymic hyperplasia: correlation with the international thymic malignancy interest group (ITMIG) stage and WHO grade
Objectives: To evaluate the effectiveness of CT texture analysis (CTTA) in (1) differentiating Thymoma (THY) from thymic hyperplasia (TH) (2) low from high WHO grade, and (3) low from high Masaoka Koga (MK)/International Thymic Malignancy Interest Group (ITMIG) stages. Methods: After institute ethical clearance, this cross-sectional study analyzed 26 patients (THY-18, TH-8) who underwent dual energy CT (DECT) and surgery between January 2016 and December 2018. CTTA was performed using TexRad (Feedback Medical Ltd., Cambridge, UK- www.fbkmed.com ) by a single observer. Free hand regions of interest (ROIs) were placed over axial sections where there was maximum enhancement and homogeneity. Filtration histogram was used to generate six first-order texture parameters [mean, standard deviation (SD), mean of positive pixels (MPP), entropy, skewness, and kurtosis] at six spatial scaling factors “SSF 0, 2, 3, 4, 5, and 6”. Mann–Whitney test was applied among various categories and p value < 0.05 was considered significant. Three-step feature selection was performed to determine the best parameters among each category. Results: The best performing parameters were (1) THY vs TH- Mean at “SSF 0” (AUC: 0.8889) and MPP at “SSF 0” (AUC: 0.8889), (2) Low vs high WHO grade - no parameter showed statistical significance with good AUC, and (3) Low vs high MK/ITMIG stage- SD at “SSF 6” (AUC: 0.8052 and 0.8333 respectively]). Conclusion: CTTA revealed several parameters with excellent diagnostic performance in differentiating thymoma from thymic hyperplasia and MK/ITMIG high vs low stages. CTTA could potentially serve as a non-invasive tool for this stratification. Advances in knowledge: This study has employed texture analysis, a novel radiomics method on DECT scans to determine the best performing parameter and their corresponding cut-off values to differentiate among the above-mentioned categories. These new parameters may help add another layer of confidence to non-invasively stratify and prognosticate patients accurately which was only previously possible with a biopsy.